THC Farmaceuticals, Inc.
CBDG · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $181 | $3,608 | $908 | $1,628 |
| - Cash | $2 | $2 | $19 | $3 |
| + Debt | $142 | $142 | $373 | $343 |
| Enterprise Value | $321 | $3,748 | $1,262 | $1,968 |
| Revenue | $0 | $10 | $2 | $8 |
| % Growth | -100% | 347.6% | -70.5% | – |
| Gross Profit | -$5 | $6 | $1 | $8 |
| % Margin | – | 61.9% | 57.4% | 100% |
| EBITDA | -$25 | $430 | -$16 | -$120 |
| % Margin | – | 4,298.7% | -709.7% | -1,580.2% |
| Net Income | -$15 | $427 | -$8 | -$60 |
| % Margin | – | 4,269.1% | -376.9% | -798% |
| EPS Diluted | -0.001 | 0.024 | -0.001 | -0.004 |
| % Growth | -103.4% | 4,800% | 86.1% | – |
| Operating Cash Flow | $636 | $318 | -$12 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $636 | $318 | -$12 | -$2 |